Key takeaways

  • Wipro Consumer Care paid Rs 256 crore for Good Home and Eva, against combined FY26 revenue of Rs 148 crore. That is about 1.7 times revenue.
  • It was Wipro Consumer Care’s 17th acquisition. This is a programme, not an opportunistic deal.
  • HUL paid Rs 2,955 crore for 90.5 per cent of Minimalist against FY24 revenue of Rs 347 crore, about 8.5 times.
  • The spread between 1.7x and 8.5x is category, gross margin, pricing power and whether you are selling from strength or exhaustion.
  • At 1.7 times revenue with a normal preference stack, two founders can split under Rs 20 crore before tax on a Rs 256 crore sale.

A revenue of about Rs 150 crore, a purchase price of Rs 256 crore. That is a multiple of 1.7. I would not call that a good exit multiple in D2C. It happened anyway, and it is going to keep happening, which is why this deal is worth more attention than it got.

The number itself is not the story. The story is that a founder who spends nine years building a Rs 150 crore brand and a founder who spends four years building a Rs 350 crore brand can walk away with outcomes that differ by more than an order of magnitude, and most of that difference is decided before either of them starts negotiating.

Rs 256 cr
Wipro Consumer paid
for Good Home and Eva, from TTK Healthcare
Rs 148 cr
Combined FY26 revenue
of the two brands being sold
1.7x
The exit multiple
against 8.5x for Minimalist a year earlier

The spread is the whole article

Wipro Consumer to Good Home + Eva1.7xITC to Sproutlife, Yoga Bar, implied5.1xHUL to Minimalist8.5x
Indian consumer brand exits, price as a multiple of revenue — Three deals, three very different prices for a rupee of revenue. Three points, not a trend line
Source: Company disclosures via Entrackr, Inc42 and Business Standard

Three deals, and I will say plainly that three points is not a trend line. But the range is the point. A rupee of Minimalist revenue was worth five times a rupee of Good Home revenue to a buyer. Same country, same year, same type of acquirer, same category of transaction. The brands were not five times better. They were in different positions.

The exit spread, deal by deal
Deal Price Revenue base Multiple
Wipro Consumer to Good Home + Eva, 2026 Rs 256 crore Rs 148 crore, FY26 combined ~1.7x
ITC to Sproutlife, Yoga Bar, May 2023 Rs 175 crore for ~39 per cent Rs 88 crore, FY23 ~5.1x implied
HUL to Minimalist, Jan 2025 Rs 2,955 crore for 90.5 per cent Rs 347 crore, FY24 ~8.5x

Source: Entrackr, Inc42, Business Standard, company filings

One correction worth making, because it gets reported loosely. ITC did not buy Yoga Bar for Rs 175 crore. It bought about 39 per cent of Sproutlife Foods for Rs 175 crore in May 2023, which implies a whole-company value near Rs 450 crore against FY23 revenue of Rs 88 crore. Roughly 5 times, and ITC only took control in April 2026, three years later. That staged structure matters, and I come back to it below.

What actually separates an 8.5x from a 1.7x

What gets you 8xWhat gets you 1.7xBeauty and personal care, not home careCommodity-adjacent categoryGross margin the buyer cannot replicateMargin close to the category averagePrice rises without losing volumeThe shelf sets the price, not the brandGrowing 40 per cent plus at the point of saleGrowth flat, sold out of a portfolioSeller has more than one optionSeller wants out of the category
What separates a premium exit from an escape — A framework, not a scorecard for any single deal. Category and pricing power do most of the work
Source: Author’s analysis

Category does most of the work. Beauty and personal care carries gross margins a large buyer cannot easily replicate in-house, so the buyer is paying for margin it cannot build. Home care sits closer to commodity: the shelf sets the price, the buyer already owns distribution, and the only thing being bought is a bit of shelf share and a formulation. Minimalist was also growing about 48 per cent, to Rs 515 crore in FY25, at the point HUL was buying. Growth at the moment of sale is worth more than growth in your history.

The honest counter-fact: 1.7x is not automatically a bad decision. TTK Healthcare is a listed company cleaning up a portfolio, not a founder cashing out, and for a corporate seller a clean Rs 256 crore of cash for two non-core brands can be exactly right. The multiple only becomes a trap when the seller is a venture-funded founder with a preference stack behind them.

Why the buyer sets the multiple

1The listing door shutsFive Indian startup IPOs were deferred in 2026. For a brand doing Rs 150crore of revenue, a listing was never the plan anyway.2M&A becomes the only exitSecondary markets for private Indian consumer brands are thin. A strategicsale is not one option, it is the option set.3Count the buyers who can write the chequeHUL, ITC, Marico, Dabur, Emami, Godrej, Wipro Consumer. Fewer than tencompanies do these deals at scale.4The buyer sets the priceOne side has seven alternatives and the other has one. The multiple stopsbeing about brand quality and starts being about leverage.
Why the buyer sets the multiple, not the founder — The spread between 1.7x and 8.5x is mostly explained by which side of this had options
Source: Author’s analysis

This is the mechanism, and it is not about negotiation skill. When the listing window shuts, the entire exit route for a mid-size consumer brand collapses into one channel, and that channel has fewer than ten serious buyers. I wrote about how India recorded zero venture rounds above 100 million dollars in the first quarter of 2026, and this is the downstream consequence. What would change it: a functioning small-cap listing route for profitable Rs 200 to 500 crore consumer brands, or a private equity buyer class willing to hold consumer brands for eight years. Neither exists at scale in India today.

The staged deal is the quiet part

May 2023ITC buys about 39 per cent of Sproutlife Foods, the Yoga Bar owner, for Rs 175 croreJan 2025HUL buys 90.5 per cent of Minimalist at a Rs 2,955 crore valuation, the largest Indian beauty D2C dealApr 2026ITC takes control of Sproutlife with about 47.5 per cent, three years after the first tranche2026Wipro Consumer buys Good Home and Eva from TTK Healthcare for Rs 256 crore, its 17th acquisition
The consolidation is not a moment, it is a queue — Large buyers now take staged stakes and convert to control later, which caps the price at every step
Source: Entrackr, Business Standard, Storyboard18, company filings

Notice what ITC did. A 39 per cent stake in 2023, more capital in 2024, control in 2026. Every tranche is priced against the last one, which means the first cheque anchors the whole outcome. A founder who sells 39 per cent early has effectively sold the option to run a competitive process later. That is a better deal for the buyer than a single clean acquisition, and it is becoming the default structure.

The founder waterfall nobody publishes

Sale price: Rs 256 cr90%Liquidation preference paid to investors firstRs 230 cr (90%)ESOP pool share of what is leftRs 10 cr (4%)6%Both founders combined, before taxRs 16 cr (6%)
Where a Rs 256 crore sale actually goes — Illustrative model: Rs 200 crore raised over five rounds, 1x preference on Rs 140 crore and 1.5x on the last Rs 60 crore, founders on 18 per cent of the cap table. Not the Good Home deal, whose seller was a listed company
Source: Author’s analysis

Here is the arithmetic that does not appear in the press release. Take a venture-funded brand that raised Rs 200 crore across five rounds over nine years, with a standard 1x liquidation preference on Rs 140 crore of it and a 1.5x preference on the last Rs 60 crore, raised under pressure. That is a preference stack of Rs 230 crore. The brand sells for Rs 256 crore, the same 1.7 times revenue.

The investors compare their preference with converting to common. On 72 per cent of the cap table, converting is worth about Rs 184 crore, so they take the Rs 230 crore preference instead. That leaves Rs 26 crore for common stock. The ESOP pool takes its share, and the two founders split roughly Rs 16 crore before tax. After long-term capital gains at 12.5 per cent, that is about Rs 7 crore each for nine years of work, or under Rs 80 lakh a year. The same nine years spent as a senior operator at the listed company that just bought them would in most cases have paid more, with none of the risk.

To be clear, this is an illustrative model, not the Good Home transaction. TTK Healthcare is a listed corporate seller with no preference stack behind it. I am using the same multiple to show what that multiple does to a venture-funded cap table, because that is the case most founders reading this are actually in. And note the asymmetry: this outcome is set by the preference terms agreed years earlier, not by the sale negotiation. By the time you are in the room, the waterfall is already written.

My prediction, so you can grade it

  1. The median Indian D2C acquisition multiple in FY27 sits below 3 times revenue. The 8x deals will be rare and concentrated in beauty and personal care.
  2. Staged acquisitions, a minority stake first and control two to four years later, become the majority structure for deals above Rs 200 crore.
  3. At least three Indian D2C brands that raised above Rs 150 crore sell in FY27 at a price where the founders clear less than Rs 10 crore each.
  4. No mid-size Indian consumer D2C brand completes a mainboard IPO before FY28.

How to build a brand that exits at 8x

Pick the category before you pick the product. Gross margin structure is set at the category level and you cannot out-execute it. This is the single highest-leverage decision you make, and you make it in year one.

Prove pricing power, then show it to the buyer. One clean price increase with volume intact is worth more in a diligence room than two years of revenue growth bought with discounts.

Raise less, and negotiate the preference harder than the valuation. A higher headline valuation with a 1.5x participating preference is worse than a lower one on clean terms. Founders trade this away constantly because the valuation is the number their friends ask about.

Sell while you are still growing. The multiple tracks your growth rate at the moment of sale, not your peak. Every quarter of flat growth costs you multiple, and the cost compounds.

Manufacture a second option. Even a credible one. The entire 1.7x versus 8.5x spread is a story about who had alternatives.

The counter-argument, honestly: not every brand can be in beauty and personal care, and a real Rs 256 crore beats an imaginary Rs 2,000 crore. If your growth has stalled and your capital is running down, taking 1.7x today is often better than taking 1.2x in eighteen months. What I am arguing against is walking into that room without knowing which of the two situations you are in. Similar arithmetic governs what actually happens inside quick commerce unit economics, where the category, not the operator, sets the ceiling.

Read next

For the layer above this one, read the audit of India’s 70 unpriced unicorns, and for the capital side, who is actually left to fund Indian companies.

Sources

  • Reported terms of the Wipro Consumer Care purchase of Good Home and Eva from TTK Healthcare, Rs 256 crore against Rs 148 crore of combined FY26 revenue
  • Entrackr and Inc42 on HUL acquiring 90.5 per cent of Minimalist at a Rs 2,955 crore valuation, January 2025
  • Minimalist FY24 revenue of Rs 347.4 crore and FY25 revenue of Rs 514.8 crore with a net loss of Rs 31.5 crore, via Storyboard18
  • Business Standard and Storyboard18 on ITC acquiring about 39 per cent of Sproutlife Foods for Rs 175 crore in May 2023 and taking control in April 2026

Figures are as reported by the sources named above at the time of writing. The founder waterfall is an illustrative model on the assumptions stated and does not describe any specific transaction.

Get the day’s top stories in your inbox

One concise email. No spam, unsubscribe anytime.